Communicating her equipment and tool needs



1. Imaging
Imaging of the pancreas is difficult, improving image quality will help provide better health outcomes.

2. Differentiation of gastrinomas
Differentiating whether a patient has gastrinoma as opposed to other types of cancers.



Secretin is an adjunct to ultrasound and resonance magnetic imaging in inflammatory conditions of the pancreas, such as chronic pancreatitis. The periductal fibrosis present in the chronically inflamed pancreas limits the dilatation of the main duct after maximal secretin stimulation, which is used to distinguish chronic pancreatitis from the normal pancreas. This is a non-invasive surgical assessment used for pancreatic transplant/whipple procedure (pancreaticoduodenectomy) , pancreatic remnant, and pancreatic leak. 

Secretin-stimulated MRCP provides dynamic assessment of the pancreatic function and reserve, identifies pancreatic ductal integrity, and allows for the evaluation of surgical anastomosis.

Secretin Stimulation Test for Gastrinoma

Zollinger-Ellison syndrome (ZES) is caused by a gastrin-producing neuroendocrine tumor (gastrinoma), characterized by symptoms of gastric acid hypersecretion, i.e. peptic ulcer disease, malabsorption and diarrhea. The secretin stimulation test is the diagnostic tool of choice in subjects with FSG levels <1,000 ng/l (Kuiper, Jansen, et. al., 2010)